EC Number   |
Disease   |
PubMed ID   |
Title of Publication   |
Category |
Confidence Level |
|---|
 2.4.1.219 | Diabetes Mellitus |
29026604 |
Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study. |
causal interaction |
3 |
 2.4.1.219 | Diabetes Mellitus |
23657005 |
Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study. |
diagnostic usage |
2 |
 2.4.1.219 | Diabetes Mellitus |
22098444 |
Effects of transglucosidase on diabetes, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial. |
diagnostic usage |
1 |
 2.4.1.219 | Diabetes Mellitus |
23657005 |
Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study. |
therapeutic application |
2 |
 2.4.1.219 | Diabetes Mellitus |
29026604 |
Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study. |
therapeutic application |
4 |
 2.4.1.219 | Diabetes Mellitus |
22098444 |
Effects of transglucosidase on diabetes, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial. |
therapeutic application |
2 |
 2.4.1.219 | Diabetes Mellitus |
23657005 |
Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study. |
ongoing research |
3 |
 2.4.1.219 | Diabetes Mellitus |
29026604 |
Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study. |
ongoing research |
2 |
 2.4.1.219 | Diabetes Mellitus |
22098444 |
Effects of transglucosidase on diabetes, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial. |
ongoing research |
3 |
 2.4.1.219 | Diabetes Mellitus |
23657005 |
Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study. |
unassigned |
0 |